Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications
Authors
Keywords
-
Journal
Cells
Volume 11, Issue 6, Pages 934
Publisher
MDPI AG
Online
2022-03-10
DOI
10.3390/cells11060934
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Breast Cancer Stem Cells Traits and Drug Resistance
- (2021) Qinghui Zheng et al. Frontiers in Pharmacology
- PCA062, a P-cadherin targeting antibody-drug-conjugate, displays potent anti-tumor activity against P-cadherin-expressing malignancies
- (2021) Qing Sheng et al. MOLECULAR CANCER THERAPEUTICS
- Signaling pathways governing breast cancer stem cells behavior
- (2021) Kai Song et al. Stem Cell Research & Therapy
- Molecular imaging reveals biodistribution of P-cadherin LP-DART bispecific and trafficking of adoptively transferred T cells in mouse xenograft model
- (2020) Vijay R. Gupta et al. Oncotarget
- Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells
- (2020) Zahra Eslami-S et al. Cells
- Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
- (2020) Jennifer R. Diamond et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors
- (2020) Vivek Subbiah et al. CLINICAL CANCER RESEARCH
- Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1
- (2020) Huimin Jiang et al. Nature Communications
- The Chick Chorioallantoic Membrane Model: A New In Vivo Tool to Evaluate Breast Cancer Stem Cell Activity
- (2020) Marta Teixeira Pinto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications
- (2020) Xiaobin Zeng et al. PHARMACOLOGICAL RESEARCH
- Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond
- (2020) Xiaoli Zhang et al. Cancers
- Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
- (2019) Chiara Agnoletto et al. Cancers
- CD133 in Breast Cancer Cells: More than a Stem Cell Marker
- (2019) Federica Brugnoli et al. Journal of Oncology
- Abstract B24: Stem cell lineage infidelity drives wound repair and cancer
- (2018) Yejing Ge et al. CANCER RESEARCH
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer
- (2018) Mingshan Liu et al. Molecular Cancer
- α6-Integrin alternative splicing: distinct cytoplasmic variants in stem cell fate specification and niche interaction
- (2018) Zijing Zhou et al. Stem Cell Research & Therapy
- Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
- (2018) Sònia Palomeras et al. MOLECULES
- Prognostic value of CD44v6 expression in breast cancer: a meta-analysis
- (2018) Guang-Lei Qiao et al. OncoTargets and Therapy
- SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
- (2018) Peng Liu et al. Frontiers in Pharmacology
- Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
- (2018) Chitra Joseph et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Cancer stem cell pipeline flounders
- (2018) Ken Garber NATURE REVIEWS DRUG DISCOVERY
- CD24 expression and stem-associated features define tumor cell heterogeneity and tumorigenic capacities in a model of carcinogenesis
- (2018) Paola Ortiz-Montero et al. Cancer Management and Research
- P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice
- (2017) André Filipe Vieira et al. MODERN PATHOLOGY
- Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation
- (2017) Xiangrong Sharon Qi et al. RADIOTHERAPY AND ONCOLOGY
- The challenge of targeting cancer stem cells to halt metastasis
- (2017) Alice Agliano et al. SEMINARS IN CANCER BIOLOGY
- The Role of Integrin α6 (CD49f) in Stem Cells: More than a Conserved Biomarker
- (2017) Paul H. Krebsbach et al. STEM CELLS AND DEVELOPMENT
- Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance
- (2017) Jae Moon Gwak et al. Oncotarget
- Drugging Membrane Protein Interactions
- (2016) Hang Yin et al. Annual Review of Biomedical Engineering
- Breast cancer stem cell: the roles and therapeutic implications
- (2016) Fang Yang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
- (2016) Eameema Muntimadugu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells
- (2016) S Bhatt et al. ONCOGENE
- Major Contributions towards Finding a Cure for Cancer through Chemotherapy: A Historical Review
- (2016) Imran Masood et al. TUMORI
- Major Contributions towards Finding a Cure for Cancer through Chemotherapy: A Historical Review
- (2016) Imran Masood et al. TUMORI JOURNAL
- P-cadherin and the journey to cancer metastasis
- (2015) André Filipe Vieira et al. Molecular Cancer
- How Does Multistep Tumorigenesis Really Proceed?
- (2015) Christine L. Chaffer et al. Cancer Discovery
- P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells
- (2015) André Filipe Vieira et al. Oncotarget
- Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
- (2015) Gyu-Beom Jang et al. Scientific Reports
- CD44-Targeted Docetaxel Conjugate for Cancer Cells and Cancer Stem-Like Cells: A Novel Hyaluronic Acid-Based Drug Delivery System
- (2014) Navid Goodarzi et al. Chemical Biology & Drug Design
- ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1
- (2014) Peijing Zhang et al. NATURE CELL BIOLOGY
- Metabolic requirements for the maintenance of self-renewing stem cells
- (2014) Keisuke Ito et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
- (2014) J Diessner et al. Cell Death & Disease
- Regulated Splicing of the α6 Integrin Cytoplasmic Domain Determines the Fate of Breast Cancer Stem Cells
- (2014) Hira Lal Goel et al. Cell Reports
- Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape?
- (2014) Valentin S. Bruttel et al. Frontiers in Immunology
- HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
- (2013) S. Ithimakin et al. CANCER RESEARCH
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
- (2013) Christine L. Chaffer et al. CELL
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society
- (2013) Nadire Duru et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness
- (2013) Federica Brugnoli et al. Molecular Cancer
- Cancer stem cells and their role in metastasis
- (2013) Yusuke Shiozawa et al. PHARMACOLOGY & THERAPEUTICS
- Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
- (2013) L. Magnani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of the cancer stem cell related determinants of radioresistance
- (2013) Claudia Peitzsch et al. RADIOTHERAPY AND ONCOLOGY
- Epithelial E- and P-cadherins: Role and clinical significance in cancer
- (2012) Joana Paredes et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
- (2012) J. K. Singh et al. CLINICAL CANCER RESEARCH
- HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
- (2012) N. Duru et al. CLINICAL CANCER RESEARCH
- Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress
- (2012) Surendra Singh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
- (2012) Francisco Ferro de Beça et al. JOURNAL OF CLINICAL PATHOLOGY
- P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model
- (2012) Ana Sofia Ribeiro et al. JOURNAL OF PATHOLOGY
- CD24−/low stem-like breast cancer marker defines the radiation-resistant cells involved in memorization and transmission of radiation-induced genomic instability
- (2012) J Bensimon et al. ONCOGENE
- P-Cadherin Is Coexpressed with CD44 and CD49f and Mediates Stem Cell Properties in Basal-like Breast Cancer
- (2012) André Filipe Vieira et al. STEM CELLS
- An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
- (2011) H E Lee et al. BRITISH JOURNAL OF CANCER
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells
- (2011) Erika Pastrana et al. Cell Stem Cell
- Mammalian plasma membrane proteins as potential biomarkers and drug targets
- (2011) Marijana Rucevic et al. ELECTROPHORESIS
- Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
- (2011) Phuc V Pham et al. Journal of Translational Medicine
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- Tumor-Initiating Cells Are Rare in Many Human Tumors
- (2010) Kota Ishizawa et al. Cell Stem Cell
- PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity
- (2010) C. C. Zhang et al. CLINICAL CANCER RESEARCH
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer
- (2010) Ji ONCOLOGY REPORTS
- Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models
- (2010) H. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis
- (2010) Paola Marcato et al. STEM CELLS
- An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
- (2009) M. Schmidt et al. ANNALS OF ONCOLOGY
- Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
- (2009) Panayiotis A. Theodoropoulos et al. CANCER LETTERS
- Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
- (2009) E. Charafe-Jauffret et al. CLINICAL CANCER RESEARCH
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells
- (2009) A S Ribeiro et al. ONCOGENE
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
- (2008) Alysha K. Croker et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now